Atlas Trials

A Study on Postmarketing Xuezhikang Capsule for Treating Dyslipidemia

Clinical trial NCT02057302 · COMPLETED

Trial details

NCT number
NCT02057302
Sponsor
China Academy of Chinese Medical Sciences
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Dyslipidemia
Start date
2010-03-01
Primary completion
2012-12-01
Enrollment
2400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.